BACKGROUND: Macrovesicular steatosis is assumed to be an important risk factor for early allograft dysfunction (EAD) after orthotopic liver transplantation (OLT). AIM: To evaluate the impact of steatosis in combination with other risk factors on the outcome of OLT. METHODS: The degree of steatosis was analysed in 165 consecutive OLTs and was classified by histological examination as non (M0), mild (<30%, M1), moderate (30-60%, M2) or severe steatosis (>60%, M3). Recipients were analysed for EAD. RESULTS: EAD was observed in 28% of patients with M0, 26% with M1, 53% with M2 and 73% with M3 (P < 0.001). Patients with EAD had a significantly shorter graft survival after liver transplantation (P = 0.005) but did not correlate with survival. In multivariate regression analysis, the grade of steatosis, donating after cardiocirculatory death (DCD) grafts and duration of cold ischaemia time were significantly associated with EAD (P < 0.001, P = 0.01 and P = 0.001, respectively). CONCLUSION: Livers with severe (M3) steatosis from DCD donors, combined with a prolonged CIT have a high risk for developing EAD which is correlated with shorter graft survival. Therefore M3 livers should only be considered for OLT in selected recipients without the presence of additional risk factors.
BACKGROUND:Macrovesicular steatosis is assumed to be an important risk factor for early allograft dysfunction (EAD) after orthotopic liver transplantation (OLT). AIM: To evaluate the impact of steatosis in combination with other risk factors on the outcome of OLT. METHODS: The degree of steatosis was analysed in 165 consecutive OLTs and was classified by histological examination as non (M0), mild (<30%, M1), moderate (30-60%, M2) or severe steatosis (>60%, M3). Recipients were analysed for EAD. RESULTS:EAD was observed in 28% of patients with M0, 26% with M1, 53% with M2 and 73% with M3 (P < 0.001). Patients with EAD had a significantly shorter graft survival after liver transplantation (P = 0.005) but did not correlate with survival. In multivariate regression analysis, the grade of steatosis, donating after cardiocirculatory death (DCD) grafts and duration of cold ischaemia time were significantly associated with EAD (P < 0.001, P = 0.01 and P = 0.001, respectively). CONCLUSION: Livers with severe (M3) steatosis from DCD donors, combined with a prolonged CIT have a high risk for developing EAD which is correlated with shorter graft survival. Therefore M3 livers should only be considered for OLT in selected recipients without the presence of additional risk factors.
Authors: T M Fishbein; M I Fiel; S Emre; O Cubukcu; S R Guy; M E Schwartz; C M Miller; P A Sheiner Journal: Transplantation Date: 1997-07-27 Impact factor: 4.939
Authors: S Todo; A J Demetris; L Makowka; L Teperman; L Podesta; T Shaver; A Tzakis; T E Starzl Journal: Transplantation Date: 1989-05 Impact factor: 4.939
Authors: R Adam; M Reynes; M Johann; M Morino; I Astarcioglu; I Kafetzis; D Castaing; H Bismuth Journal: Transplant Proc Date: 1991-02 Impact factor: 1.066
Authors: Peter L Abt; Niraj M Desai; Michael D Crawford; Lisa M Forman; Joseph W Markmann; Kim M Olthoff; James F Markmann Journal: Ann Surg Date: 2004-01 Impact factor: 12.969
Authors: W A Marsman; R H Wiesner; L Rodriguez; K P Batts; M K Porayko; J E Hay; G J Gores; R A Krom Journal: Transplantation Date: 1996-11-15 Impact factor: 4.939
Authors: R J Ploeg; A M D'Alessandro; S J Knechtle; M D Stegall; J D Pirsch; R M Hoffmann; T Sasaki; H W Sollinger; F O Belzer; M Kalayoglu Journal: Transplantation Date: 1993-04 Impact factor: 4.939
Authors: Glauco Adrieno Westphal; Valter Duro Garcia; Rafael Lisboa de Souza; Cristiano Augusto Franke; Kalinca Daberkow Vieira; Viviane Renata Zaclikevis Birckholz; Miriam Cristine Machado; Eliana Régia Barbosa de Almeida; Fernando Osni Machado; Luiz Antônio da Costa Sardinha; Raquel Wanzuita; Carlos Eduardo Soares Silvado; Gerson Costa; Vera Braatz; Milton Caldeira Filho; Rodrigo Furtado; Luana Alves Tannous; André Gustavo Neves de Albuquerque; Edson Abdala Journal: Rev Bras Ter Intensiva Date: 2016-09
Authors: Kyle R Jackson; Jennifer D Motter; Christine E Haugen; Jane J Long; Betsy King; Benjamin Philosophe; Allan B Massie; Andrew M Cameron; Jacqueline Garonzik-Wang; Dorry L Segev Journal: Transplantation Date: 2019-11-20 Impact factor: 4.939
Authors: Faisal A Abaalkhail; Mohammed I Al Sebayel; Mohammed A Shagrani; Wael A O'Hali; Nasser M Almasri; Abduljaleel A Alalwan; Mohammed Y Alghamdi; Hamad Al-Bahili; Mohammed S AlQahtani; Saleh I Alabbad; Waleed K Al-Hamoudi; Saleh A Alqahtani Journal: Saudi Med J Date: 2021-09 Impact factor: 1.422
Authors: Ricardo C Gehrau; Valeria R Mas; Catherine I Dumur; Jihee L Suh; Ashish K Sharma; Helen P Cathro; Daniel G Maluf Journal: Transplantation Date: 2015-12 Impact factor: 4.939
Authors: Simon Moosburner; Joseph M G V Gassner; Maximilian Nösser; Julian Pohl; David Wyrwal; Felix Claussen; Paul V Ritschl; Duska Dragun; Johann Pratschke; Igor M Sauer; Nathanael Raschzok Journal: HPB Surg Date: 2018-11-01
Authors: Kyle R Jackson; Jennifer D Motter; Christine E Haugen; Jane J Long; Betsy King; Benjamin Philosophe; Allan B Massie; Andrew M Cameron; Jacqueline Garonzik-Wang; Dorry L Segev Journal: Transplantation Date: 2020-08 Impact factor: 5.385